Gerald Spotts

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

R. Brad Jones, Lishomwa C. Ndhlovu, Jason D. Barbour et al. · The Journal of Experimental Medicine · 2008 · 743 citations · Full text

Progressive Hiv-1 Infection, Progressive Loss, T-regulatory Cell +20

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 320 citations

Factor Viii Levels, Medicine, Hematology +7

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Sven Björkman, Myungshin Oh, Gerald Spotts et al. · Blood · 2011 · 204 citations · Full text

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

Peter W. Collins, Sven Björkman, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2009 · 186 citations

Thrombosis, Hematology, Hemostasis +8

Plasma and albumin‐free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients

Victor S. Blanchette, Amy D. Shapiro, Ri Liesner et al. · Journal of Thrombosis and Haemostasis · 2008 · 142 citations

Pediatric Hematology, Hematology, Pediatrics +3